Learn about Microlyte Matrix from one of our co-founders, Dr. Michael Schurr
Imbed Biosciences Inc. is a privately held medical device company emerging as a leader in the development of advanced therapies for the treatment of burns, chronic ulcers, gastro-intestinal defects, and soft-tissue repair. The company has a portfolio of products in development based on its patented Microlyte® Matrix technology that presents bioactive molecules on tissue surfaces to combat local pain and infections. The microscale matrix accelerates cell migration and reduces antibiotic/opioid abuse. Company is registered with U.S. FDA as a medical device manufacturer and maintains an ISO 13485 certified Quality Management System.
The History of Imbed Biosciences
The Founding Team
We started as a small group with a vision.
Michael J. Schurr, MD
Ankit Agarwal, Ph.D.
Jonathan F. McAnulty, DVM, PhD
Nicholas L. Abbott, PhD
Charles J. Czuprynski, PhD
Christopher J. Murphy, DVM, PhD
2241 Pinehurst Drive
Middleton, WI 53562
M-F | 9-5 | CST